| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | ms5629-19 | Group:Control colch | Genotype:Irlox IGFRlox | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-20 | Group:Control colch | Genotype:Irlox IGFRlox | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-21 | Group:Control colch | Genotype:Irlox IGFRlox | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-22 | Group:Control colch | Genotype:Irlox IGFRlox | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-24 | Group:Control colch | Genotype:Irlox | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-25 | Group:Control colch | Genotype:Irlox | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-23 | Group:Control colch | Genotype:- | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-7 | Group:control | Genotype:IR -/- IGFR -/- | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-1 | Group:control | Genotype:Irlox IGFRlox | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-2 | Group:control | Genotype:Irlox IGFRlox | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-3 | Group:control | Genotype:Irlox IGFRlox | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-4 | Group:control | Genotype:Irlox | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-5 | Group:control | Genotype:Irlox | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-6 | Group:control | Genotype:Irlox | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-34 | Group:HFD + Colch | Genotype:Irlox IGFRlox | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-32 | Group:HFD + Colch | Genotype:Irlox | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-33 | Group:HFD + Colch | Genotype:Irlox | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-35 | Group:HFD + Colch | Genotype:Irlox | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-36 | Group:HFD + Colch | Genotype:Irlox | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-17 | Group:HFD | Genotype:Irlox IGFRlox | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-14 | Group:HFD | Genotype:Irlox | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-15 | Group:HFD | Genotype:Irlox | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-16 | Group:HFD | Genotype:Irlox | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-18 | Group:HFD | Genotype:Irlox | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-26 | Group:MIGIRKO colch | Genotype:IR -/- IGFR -/- | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-27 | Group:MIGIRKO colch | Genotype:IR -/- IGFR -/- | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-28 | Group:MIGIRKO colch | Genotype:IR -/- IGFR -/- | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-29 | Group:MIGIRKO colch | Genotype:IR -/- IGFR -/- | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-30 | Group:MIGIRKO colch | Genotype:IR -/- IGFR -/- | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-31 | Group:MIGIRKO colch | Genotype:IR -/- IGFR -/- | Treatment:Colch | uM |
| Reversed phase POSITIVE ION MODE | ms5629-10 | Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-11 | Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-12 | Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-13 | Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-8 | Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Treatment:saline | uM |
| Reversed phase POSITIVE ION MODE | ms5629-9 | Group:MIGIRKO | Genotype:IR -/- IGFR -/- | Treatment:saline | uM |
Return to study ST000514 main page
Download data matrix(Inhibition of autophagy/proteasome degradation or inhibition of protein synthesis in models of muscle insulin resistance affect amino acids metabolites in serum Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|